Newborn Jaundice Treatment Market Size, Share, Growth Trends, Phototherapy Devices and Forecast 2026–2032

The global Newborn Jaundice Treatment Market is gaining steady attention as healthcare providers continue to prioritize early diagnosis, effective treatment, and improved clinical outcomes for newborns affected by neonatal jaundice. According to recent market analysis, the global market was valued at US$431 million in 2025 and is anticipated to reach US$568 million by 2032, expanding at a CAGR of 4.1% during the forecast period 2026–2032.

Newborn jaundice is one of the most common conditions observed in infants during the first few days of life. It causes yellowing of the skin and the whites of the eyes due to elevated bilirubin levels in the bloodstream. Bilirubin is produced during the natural breakdown of red blood cells, and because a newborn’s liver may not yet be fully developed, bilirubin can accumulate in the body. In most cases, the condition is manageable, but timely treatment is essential to reduce the risk of complications.

Newborn jaundice treatment devices are primarily used in phototherapy, which is widely recognized as one of the most effective treatment methods for neonatal jaundice. Phototherapy uses light to break down bilirubin in the baby’s skin, helping the body excrete it more easily. As hospitals and caregivers seek reliable, safe, and efficient solutions for newborn care, demand for overhead phototherapy units, portable phototherapy systems, and related neonatal treatment devices is expected to continue rising.

Download Free PDF Sample Report with Full TOC, Tables & Charts Included : https://qyresearch.in/request-sample/medical-devices-consumables-global-newborn-jaundice-treatment-market-insights-industry-share-sales-projections-and-demand-outlook-2026-2032

Market Overview

The Newborn Jaundice Treatment market is being shaped by the increasing need for accessible neonatal care solutions across hospitals, maternity centers, pediatric clinics, and home healthcare settings. Phototherapy remains the primary treatment approach for most newborn jaundice cases, making phototherapy units a core part of neonatal care infrastructure.

Hospitals remain the largest application area due to the high volume of newborn deliveries, availability of trained healthcare professionals, and established neonatal monitoring systems. However, household and portable treatment solutions are also gaining attention as healthcare systems move toward patient-friendly, flexible, and cost-efficient care models.

The market includes overhead phototherapy units, portable phototherapy units, and other treatment-related devices. Overhead phototherapy units are commonly used in hospitals and neonatal intensive care units, while portable units are becoming increasingly important in smaller clinics, rural healthcare centers, and home-based care environments.

For manufacturers, investors, researchers, and healthcare suppliers, the Newborn Jaundice Treatment market presents opportunities in product innovation, portability, energy efficiency, improved light delivery, digital monitoring, user-friendly design, and regional expansion.

Market Key Drivers

One of the major drivers of the Newborn Jaundice Treatment market is the high prevalence of neonatal jaundice among newborns. Since jaundice is commonly observed shortly after birth, healthcare facilities require reliable treatment systems to manage cases quickly and safely. This creates consistent demand for phototherapy devices across maternity hospitals and neonatal units.

Another key driver is the increasing focus on newborn health and early intervention. Parents and healthcare providers are becoming more aware of the importance of monitoring bilirubin levels and treating jaundice before it becomes severe. This awareness is encouraging hospitals and clinics to invest in improved treatment technologies.

The expansion of neonatal intensive care units and pediatric healthcare infrastructure is also supporting market growth. Developing countries are improving maternal and child healthcare services, which is increasing the adoption of newborn monitoring and treatment equipment. As more healthcare facilities upgrade neonatal care capacity, demand for jaundice treatment devices is expected to grow.

Portable phototherapy units are creating additional opportunities by improving treatment access outside large hospitals. These devices are useful for smaller healthcare centers and home-based treatment under medical supervision. Their convenience, lower space requirement, and ease of use are helping expand the market beyond traditional hospital settings.

Regional Insights

North America is expected to remain an important market for Newborn Jaundice Treatment during the forecast period. The region benefits from advanced neonatal care infrastructure, strong hospital systems, high awareness of newborn health screening, and established adoption of phototherapy technologies. The United States, Canada, and Mexico represent key markets for hospital-based and portable newborn care devices.

Europe also holds a significant position in the global market, supported by well-developed healthcare systems, strong maternal and infant care programs, and continued investment in neonatal equipment. Germany, France, the United Kingdom, Italy, and other European countries are expected to contribute steadily to market demand.

Asia Pacific is projected to offer strong growth opportunities during 2026–2032. Countries such as China, Japan, South Korea, India, and Southeast Asian markets are seeing rising healthcare investments, expanding maternity care infrastructure, and increasing awareness of neonatal treatment needs. With a large newborn population and improving hospital access, Asia Pacific is expected to become an attractive region for device manufacturers.

South America, led by Brazil, is gradually expanding as healthcare providers invest in newborn care equipment and improve access to maternal and child health services. The Middle East and Africa, including Turkey, GCC countries, and African markets, are expected to develop steadily as hospital infrastructure and neonatal care awareness improve.

Market Segmentation

The global Newborn Jaundice Treatment market is segmented by type into Overhead Phototherapy Units, Portable Phototherapy Units, and Others.

Overhead Phototherapy Units are widely used in hospitals, neonatal intensive care units, and maternity wards. These systems provide targeted light exposure and are commonly preferred for clinical environments where newborns are monitored by healthcare professionals. Their established use in hospital treatment protocols makes them a major segment in the market.

Portable Phototherapy Units are gaining demand due to their flexibility, mobility, and suitability for smaller healthcare facilities and home care applications. These systems are designed to be easy to move, operate, and maintain. As home-based neonatal care and outpatient treatment models expand, portable phototherapy units are expected to see growing adoption.

The Others segment includes related newborn jaundice treatment solutions and supporting devices used in neonatal care settings. These may include specialized accessories, integrated systems, and emerging device formats designed to improve treatment convenience and clinical outcomes.

By application, the market is segmented into Hospital, Household, and Others. Hospitals represent the leading application segment due to the concentration of childbirth services and neonatal treatment facilities. Household use is expected to grow gradually as portable devices become more accessible and healthcare providers explore supervised home treatment models.

Competitive Landscape

The global Newborn Jaundice Treatment market includes several established medical device companies and specialized neonatal care solution providers. Key companies profiled in the market include GE Healthcare, Dräger, Bilimetrix, Philips, Atom Medical, Nice Neotech, MTTS, Natus Medical, Delta, Micro Lab, Ningbo David Medical Device, Beijing Julongsanyou Technology, and Dolphin Nanjing Electronics.

Competition in this market is shaped by device safety, light efficiency, durability, portability, ease of use, regulatory compliance, hospital relationships, after-sales service, and pricing strategy. Leading manufacturers are focusing on improving product performance, reducing treatment time, enhancing energy efficiency, and developing user-friendly designs for clinical and household settings.

Global companies benefit from strong brand recognition, broad distribution networks, and hospital partnerships. Regional manufacturers are also gaining traction by offering cost-effective devices suitable for local healthcare systems and emerging markets. As demand grows across Asia Pacific, South America, and the Middle East, competitive opportunities are expected to increase for both international and domestic players.

Market Trends & Dynamics

A key trend in the Newborn Jaundice Treatment market is the growing preference for LED-based phototherapy systems. LED technology offers advantages such as lower energy consumption, longer lifespan, reduced heat generation, and improved treatment efficiency. Hospitals are increasingly shifting toward advanced LED phototherapy units to improve care quality and reduce maintenance costs.

Another important trend is the rising adoption of portable and compact treatment devices. Healthcare providers are seeking flexible solutions that can be used across maternity wards, neonatal units, pediatric clinics, and home care environments. Portable devices are especially useful in regions where access to large hospital infrastructure is limited.

The market is also witnessing increased focus on newborn safety and treatment comfort. Manufacturers are designing devices with better light distribution, reduced noise, improved thermal control, and enhanced ease of operation. These improvements help support both clinical efficiency and caregiver confidence.

Digital integration is gradually influencing the market as well. Future devices may increasingly include monitoring features, treatment timers, dosage control, alarms, and data recording capabilities to support more accurate and consistent neonatal care.

Industry Chain Analysis

The Newborn Jaundice Treatment industry chain includes raw material suppliers, electronic component manufacturers, LED and light source providers, medical device manufacturers, assembly partners, testing and certification agencies, distributors, hospitals, clinics, and end users.

Upstream suppliers provide LEDs, sensors, control units, plastics, metal components, display modules, power systems, and packaging materials. Midstream manufacturers focus on device design, production, assembly, quality control, regulatory compliance, and clinical usability testing. Downstream channels include hospitals, maternity centers, pediatric clinics, neonatal intensive care units, medical distributors, online medical equipment platforms, and home healthcare providers.

The industry requires strong quality management because newborn care devices must meet high safety and reliability standards. Product performance, light intensity accuracy, heat management, durability, and ease of sterilization are important factors across the value chain.

Recent Development

Recent developments in the Newborn Jaundice Treatment market are focused on improving phototherapy efficiency, device portability, LED performance, and user-friendly design. Manufacturers are introducing compact models, energy-efficient systems, and devices suitable for both hospital and household applications.

There is also growing attention toward expanding access in emerging markets. Companies are working to provide affordable phototherapy solutions for hospitals and clinics in regions with high birth rates and developing neonatal care infrastructure. Partnerships with distributors, hospitals, and public health programs are expected to support wider adoption.

Product development is increasingly centered on safety, comfort, and operational simplicity. Devices with better temperature management, easy controls, clear treatment visibility, and reliable light output are expected to remain in demand.

What’s in It for You

This market provides valuable opportunities for investors, researchers, manufacturers, distributors, and healthcare stakeholders. Investors can evaluate demand growth, regional expansion potential, and competitive positioning in the neonatal care device sector. Manufacturers can identify product development opportunities in portable phototherapy, LED systems, and cost-effective treatment solutions.

Researchers can use market insights to understand technology adoption, regional healthcare trends, and demand patterns across hospital and household applications. Distributors and suppliers can identify high-potential regions and customer segments for business expansion.

For healthcare organizations, the report offers useful insights into treatment device trends, product availability, and market direction, helping them plan equipment procurement and neonatal care upgrades.

Why Purchase This Report

This report provides a detailed view of the global Newborn Jaundice Treatment market, including market size, revenue forecast, sales volume, segmentation analysis, regional outlook, competitive landscape, industry chain review, technology trends, and future demand projections.

The report is useful for medical device manufacturers, new entrants, investors, hospitals, distributors, suppliers, and research institutions looking to understand market opportunities from 2026 to 2032. It supports business planning, product strategy, regional expansion, competitive benchmarking, and investment decisions.

By purchasing this report, readers can gain a clear understanding of market drivers, growth restraints, emerging trends, leading companies, application demand, and product-level opportunities in the newborn jaundice treatment industry.

How This Report Helps Your Business Grow -

The Newborn Jaundice Treatment Market report is designed to help businesses make informed decisions and reduce uncertainty in strategic planning. It provides valuable insights for manufacturers, investors, suppliers, distributors, consultants, and research teams.

This report can help businesses:

> Make data-driven decisions based on reliable market insights

>Identify high-growth markets and profitable business opportunities

>Understand customer demand, market trends, and competitive dynamics

>Develop effective market entry and expansion strategies

>Benchmark performance against leading companies

>Optimize resource allocation and business planning

>Evaluate risks, challenges, and future opportunities

>Support investment planning and product development decisions

Get Access to the Full Report or Request Customization for Your Business Needs : https://qyresearch.in/pre-order-inquiry/medical-devices-consumables-global-newborn-jaundice-treatment-market-insights-industry-share-sales-projections-and-demand-outlook-2026-2032

Key Questions Answered in the Report

What is the projected size of the global Newborn Jaundice Treatment market by 2032?

What CAGR is expected during the forecast period 2026–2032?

Which product types are most widely used in newborn jaundice treatment?

How are overhead and portable phototherapy units shaping market demand?

Which application segments are driving adoption across hospitals and households?

Which regions offer the strongest growth opportunities?

Who are the leading manufacturers in the global Newborn Jaundice Treatment market?

What are the major trends influencing phototherapy device innovation?

How is the industry chain structured from component suppliers to healthcare providers?

What opportunities exist for new entrants and established players?

About Us:

QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.

315 Work Avenue, Raheja Woods,

Survey No. 222/1, Plot No. 25, 6th Floor,

Kayani Nagar, Yervada, Pune 411006, Maharashtra

Tel: +91-8669986909

Emails - arshad@qyrindia.com

Web -https://www.qyresearch.in